KATHRYN MADDUX: Open Payments
NPI 1194430157 · MERIDIAN, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,620 in 38 payments from 13 companies in 2025. Trend: 2023 $109 · 2024 $215 · 2025 $1,620
Food & beverage: $1,441Education: $179
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 7 | $385 |
| Galderma Laboratories, L.P. | 4 | $255 |
| Regeneron Healthcare Solutions, Inc. | 3 | $174 |
| Organon LLC | 2 | $137 |
| Incyte Corporation | 3 | $136 |
| UCB, Inc. | 2 | $113 |
| SANOFI-AVENTIS U.S. LLC | 1 | $99 |
| ABBVIE INC. | 4 | $81 |
| Novartis Pharmaceuticals Corporation | 3 | $77 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $66 |
Products named: TREMFYA, NEMLUVIO, DUPIXENT, VTAMA, OPZELURA, LIBTAYO, Bimzelx, SKYRIZI.
Industry payments across ID — which companies pay providers there.
